Hypertension and coronary heart disease;Hypertonie und koronare herzkrankheit: Globale risikomodulation durch kontrolle des körpergewichts

Praxis

Volumn 85, Issue 5, 1996, Pages 113-116

  Suter, P M ^a   Hasler, E ^a   Vetter, W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Body weight; Cardiovascular risk; Dyslipidemia; Hypertension; Obesity

Indexed keywords

BODY WEIGHT; CORONARY ARTERY DISEASE; FAT INTAKE; HUMAN; HYPERTENSION; OBESITY; REVIEW; RISK FACTOR;

BODY WEIGHT; CORONARY DISEASE; DIETARY FATS; HUMANS; HYPERTENSION; OBESITY; RISK FACTORS;

EID: 0030606369     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Wilson P.W. F.: Established risk factors and coronary artery disease: The Framingham Study. Am. J. Hypertension 7, 7S-12S, 1994.
2. Oliver J. A.: Cardiovascular disease and hypertension. Cur. Opin. Nephrol. Hypertens. 2, 299-306, 1993.
3. Hodis H. N., Cashin-Hemphill L., Mack W. J.: Prevention of coronary artery disease. Heart Dis. Stroke. July/August, 182-187, 1994.
4. Lithell H.: Pathogenesis and prevalence of atherosclerosis in hypertensive patients. Am. J. Hypertens. 7, 2S-6S, 1994.
5. Dazau V., Braunwald E. and participants: Resolved and unresolved issues in the prevention and treatment of coronary artery disease. A workshop consensus statement. Am. Heart J. 121, 1244-1263, 1991.
6. Benotti P. N., Bistrian B., Benotti J. R., Blackburn G., Farse R. A.: Heart disease and hypertension in severe obesity. The benefit of weight reduction. Am. J. Clin. Nutr. 55, 586S-590S, 1992.
7. Hubert H. B., Feinleib M., McNamara P. M., Castelli W. P.: Obesity as an independent risk factor for cardiovascular disease. A 26-year follow-up of participants in the Framingham Heart Study. Circulation 67, 968-977, 1983.
8. Hauner H., Bognar E., Blum A.: Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease. Evidence for the presence of a metabolic syndrome. Atherosclerosis 105, 209-216, 1994.
9. Scherrer U., Randin D, Tappy L., Vollenweider P., Jéquier E., Nicod P.: Body fat and sympathetic nerve activity in healthy subjects. Circulation 89, 2634-2640, 1994.
10. Suler P. M, Vetter W.: Primärprävention - Ernährung und Körpergewicht. Ther. Umschau 51, 657-662, 1994.
11. Shimokata N., Muller D. C., Andres R.: Studies on the distribution of body fat. III. Effect of cigarette smoking. J. Am. med. Ass. 261, 1169-1173, 1989.
12. Surer P. M., Schutz Y., Jéquier E.: The effect of ethanot on fat storage in healthy subjects. New Engl. J. Med. 326, 983-987, 1992.
13. Suter P M., Weisser B., Grüne S., Spahler T., Greminger P., Vetter W. J.: Übergewicht in der Schweiz. Ein Quervergleich verschiedener Studien. Schweiz. Rundschau Med. (PRAXIS) 83, 792-796, 1994.
14. Kuczmarski R. J., Flegal K. M., Campbell S. M., Johnson C. L.: Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Survey, 1960-1991. J. Am. med. Ass. 272, 205-211, 1994.
15. Flatt J. P.: Importance of nutrient balance in body weight regulation. Diabetes Metab. Rev. 4, 571-581. 1988.
16. Acheson K., Flatt J. P., Jéquier E., Glycogen synthesis versus lipogenesis after a 500 gram carbohydrate meal in man. Metabolism 31, 1234-1240, 1982.
17. Superko H. R., Krauss R. M.: Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation 90, 1056-1069, 1994.
18. Ornish D., Brown S. E., Scherwitz L. W., Billings J. H., Armstrong W. T., Ports T. A., McLanahan S. M., Kirkeeide R. L., Brand R. J., Gould K. L.: Can lifestyle changes reverse coronary artery disease? Lancet 336, 129-133, 1990.